Lucid Diagnostics Inc.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5M | $1.3M | $1.5M | $1.2M | $1.2M | $828.0K | $1.2M | $1.2M |
| Cost of Revenue | $1.4M | $1.6M | — | — | $1.6M | $1.6M | — | — |
| Gross Profit | $29.0K | $-369.0K | — | — | $-400.0K | $-723.0K | — | — |
| Gross Margin | 2.0% | -29.4% | — | — | -34.4% | -87.3% | — | — |
| Operating Expenses | ||||||||
| Research & Development | $1.2M | $1.2M | $1.7M | $1.3M | $1.3M | $1.4M | $1.5M | $1.7M |
| SG&A Expense | $5.8M | $5.4M | $6.5M | $5.6M | $5.6M | $6.2M | $5.9M | $5.4M |
| Operating Income | $-12.8M | $-12.1M | $-14.0M | $-11.8M | $-11.4M | $-12.5M | $-12.4M | $-11.7M |
| Operating Margin | -868.5% | -964.5% | -931.5% | -971.0% | -978.8% | -1,508.1% | -1,033.8% | -997.8% |
| Interest Expense | — | — | — | $2.0K | $6.0K | $9.0K | $7.0K | $1.0K |
| Pretax Income | $-11.7M | $-13.9M | $-16.3M | $-10.4M | $-4.4M | $-26.9M | $-11.5M | $-12.4M |
| Income Tax Expense | $0 | $0 | — | — | $0 | $0 | — | — |
| Net Income | $-11.7M | $-13.9M | $-16.3M | $-10.4M | $-4.4M | $-26.9M | $-11.5M | $-12.4M |
| Net Margin | -792.9% | -1,107.4% | -1,081.5% | -858.5% | -381.7% | -3,249.8% | -964.2% | -1,055.5% |
| EPS (Basic) | $-0.08 | $-0.17 | $0.01 | $-0.05 | $-0.04 | $-0.26 | $-0.09 | $-0.13 |
| EPS (Diluted) | — | — | — | $-0.05 | $-0.04 | $-0.26 | $-0.09 | $-0.13 |
| Shares Outstanding (Basic) | 183.1M | 140.1M | 101.9M | 216.4M | 198.0M | 137.6M | 101.0M | 100.7M |
| Shares Outstanding (Diluted) | 183.1M | 140.1M | 101.9M | 216.4M | 198.0M | 137.6M | 101.0M | 100.7M |
| Dividends Per Share | — | — | — | — | — | — | — | — |